Statistics
Publications
5
Citations
7.9K
H-Index
5
Active since
1990
Waldemar Szpak is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, oncology, and pembrolizumab therapy.
Publications per year
1990–2019
5
5
Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text
Medicine, Oncology, Pharmacology +15
Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text
Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
1–5 of 5